Clinical

A chronic disease of the central nervous system, multiple sclerosis (MS) is considered an immune-­mediated disorder in which the immune system attacks healthy neuronal tissue.
After more than 2 centuries of work, we now understand more about the cellular biology of rheumatoid arthritis, but the underlying cause of the disease remains elusive.
Closing Gaps in Health Plan Performance with Stakeholder Collaboration
Diabetic retinopathy (ie, damage to the small blood vessels in the retina) is one of the most common complications in patients with chronic diabetes.
The Economics of Screening Patients with Diabetes for Diabetic Retinopathy
According to the Eighth Joint National Committee, hypertension is a known risk factor for cardiovascular (CV) events, such as stroke, myocardial infarction, and heart failure. Hypertension is defined as persistent systolic/diastolic blood pressure of at least 140/90 mm Hg among patients aged 70 billion in 2010 to an estimated $200 billion in 2030. The goal of therapy in patients with hypertension is to decrease the risk for CV events (such as myocardial infarction or stroke) by reducing and controlling blood pressure.
Moving Beyond Measures into Outcomes in Hypertension Research
Bipolar disorder is a chronic, relapsing illness characterized by recurrent episodes of manic or depressive symptoms, with intervening periods that are relatively (but not fully) symptom-free.
Bipolar Disorders: Balancing Formulary Management and Clinical Outcomes for a Vulnerable Patient Population
Venous thromboembolism (VTE) encompasses deep-vein thrombosis (DVT) and pulmonary embolism (PE). VTE is a chronic disease that is associated with a high risk for recurrence, especially during the initial months of therapy.
Better Compliance with Clinical Guidelines for Venous Thromboembolism Can Improve Patient Outcomes, Reduce Costs
Type 2 diabetes mellitus is an ongoing medical problem that clinicians deal with on a daily basis. The necessity of treating diabetes adequately is essential because of the many comorbidities and complications associated with uncontrolled diabetes.
Addressing Adherence a Key Challenge in the Management of Patients with Type 2 Diabetes
The development of innovative medications is largely a private enterprise that relies chiefly on the investment of pharmaceutical companies in research and development (R&D).
Accurate Prescribing Key to Safe Use of Anticoagulants in Patients with Nonvalvular Atrial Fibrillation
The development of innovative medications is largely a private enterprise that relies chiefly on the investment of pharmaceutical companies in research and development (R&D).
Predicting Behavior: It’s a Matter of Preference
Azithromycin has been used for many years for the treatment of patients with various types of bacterial infections, as well as for the secondary prevention of coronary events. There is a growing concern, however, that azithromycin may be associated with an increased cardiovascular (CV) risk and may lead to CV-related death in high-risk patients.
Cardiovascular Safety of Azithromycin Therapy: Revisiting the Evidence
Page 6 of 13
Results 51 - 60 of 124
  •  Association for Value-Based Cancer Care
  • Oncology Practice Management
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Rheumatology Practice Management
  • Urology Practice Management
  • Lynx CME